Dispatch Bio is building a system that could broaden treatment for a wide variety of tumors, and it’s about to start testing ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc.

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

In its 80th year, the world's second-oldest film festival, taking over a Czech spa town, is still celebrating premieres, and ...

Both parties are committed to exploring establishment of an AI enabled obesity healthcare model to deliver advanced, ...

Neil Gallagher, MD, PhD, joins with over 25 years clinical development experience, having contributed to multiple commercial therapeutics across ...

A robotic bird that mimics kestrel movements has helped researchers uncover how birds maintain stability in turbulent air ...

Spread the love“`html As we mark 250 years of American science, a paradox emerges: the nation renowned for its groundbreaking innovations is experiencing a significant decline in research funding ...

School of Medicine and GlyTR Therapeutics have developed a next?generation AAV?mediated CAR T?cell platform, GlyTR (pronounced 'glitter'), engineered to target tumor?associated carbohydrate ...